(Q37569470)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Sorafenib and sunitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

AeRang Kim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Brigitte C Widemann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

800-805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

Protein kinase-mediated signaling networks. Regulation and functional characterization.

4 February 2020

cites work

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

12 December 2020

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics

1 reference

12 December 2020

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

1 reference

12 December 2020

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

1 reference

12 December 2020

1 reference

12 December 2020

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib

1 reference

12 December 2020

1 reference

12 December 2020

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

12 December 2020

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

1 reference

12 December 2020

Sorafenib: delivering a targeted drug to the right targets

1 reference

12 December 2020

Sorafenib and sunitinib: novel targeted therapies for renal cell cancer

1 reference

12 December 2020

A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities

1 reference

12 December 2020

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors

1 reference

12 December 2020

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Sorafenib: a review of its use in advanced hepatocellular carcinoma

1 reference

12 December 2020

Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301

1 reference

12 December 2020

10.1634/THEONCOLOGIST.2009-0088

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

release_re3rgcza2feijpknyhcovajjxe

4 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/re3rgcza2feijpknyhcovajjxe

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648603%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

19648603

1 reference